|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.8 SEK | +0.81% |
|
+0.40% | +26.97% |
| 05-08 | Transcript : Devyser Diagnostics AB, Q1 2024 Earnings Call, May 08, 2024 | |
| 05-08 | Devyser Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Devyser Diagnostics AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 45.4 million compared to SEK 34.2 million a year ago. Net loss was SEK 13.1 million compared to SEK 16.7 million a year ago.
Basic loss per share from continuing operations was SEK 0.8 compared to SEK 1.04 a year ago. Diluted loss per share from continuing operations was SEK 0.8 compared to SEK 1.04 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +26.97% | 148M | |
| +17.96% | 47.02B | |
| +48.77% | 41.86B | |
| +1.17% | 41.76B | |
| -4.27% | 28.8B | |
| +11.42% | 26.05B | |
| -21.39% | 19.15B | |
| +4.86% | 12.55B | |
| +27.29% | 12.34B | |
| -3.50% | 11.82B |
DEVYSER DIAGNOSTICS AB 
